[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-29675":3,"doc-seo-29675":21},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":4,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"update_tm":20},29675,7971461740909,"Levi","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d",7,"Healthcare","Anti-Coagulants Fondaparinux","This document provides critical information regarding the anticoagulant Fondaparinux, highlighting its major advantage of having no risk for Heparin-Induced Thrombocytopenia (HIT). It emphasizes crucial cautions for its administration, specifically advising against its use in patients reporting severe back pain, decreased levels of consciousness, or paralysis. In such cases, immediate contact with the Healthcare Provider (HCP) and suspension of the medication are mandatory. A key term to remember is that Fondaparinux can cause an epidural bleed, necessitating a strict protocol of holding the medication for at least 6 hours post-surgery and never administering anticoagulants in conjunction with a spinal epidural catheter. The document uses abbreviations like HCP and NCLEX KEY TERMS to denote critical points for healthcare professionals, particularly those preparing for licensing exams. The visual aid depicts a person lying on their side, possibly illustrating a patient scenario or a medical position, further reinforcing the medical context of the information presented. The comprehensive nature of these guidelines aims to ensure patient safety and prevent serious complications associated with Fondaparinux therapy.","cbCaipTnVUx3D9HF","https://ap.wps.com/l/cbCaipTnVUx3D9HF","pdf",706269,1,1778283827,{"code":4,"msg":22,"data":23},"ok",{"site_id":24,"language":25,"slug":26,"title":13,"keywords":27,"description":14,"schema_data":28,"social_meta":62,"head_meta":64,"extra_data":66,"updated_unix":20},105,"en","anti-coagulants-fondaparinux","",{"@graph":29,"@context":61},[30,47],{"@type":31,"itemListElement":32},"BreadcrumbList",[33,37,41,44],{"item":34,"name":35,"@type":36,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":38,"name":39,"@type":36,"position":40},"https://docshare.wps.com/document/","Document",2,{"item":42,"name":12,"@type":36,"position":43},"https://docshare.wps.com/document/healthcare/",3,{"item":45,"name":13,"@type":36,"position":46},"https://docshare.wps.com/document/anti-coagulants-fondaparinux/29675",4,{"url":45,"name":13,"@type":48,"author":49,"headline":13,"publisher":51,"fileFormat":54,"description":14,"dateModified":55,"datePublished":55,"encodingFormat":54,"isAccessibleForFree":56,"interactionStatistic":57},"DigitalDocument",{"name":9,"@type":50},"Person",{"url":34,"name":52,"@type":53},"DocShare","Organization","application/pdf","2026-05-08",true,{"@type":58,"interactionType":59,"userInteractionCount":4},"InteractionCounter",{"@type":60},"ViewAction","https://schema.org",{"og:url":45,"og:type":63,"og:title":13,"og:site_name":52,"og:description":14},"article",{"robots":65,"canonical":45},"index,follow",{"doc_id":7,"site_id":24}]